Translate

Wednesday, May 1, 2019

HER2 positive breast cancer: Treatment de-escalation needs to be personalized

De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be personalized, according to an expert.

from Breast Cancer News -- ScienceDaily http://bit.ly/2J86Otx

0 comments:

Post a Comment